| Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers (NCT02349412) | Alliance for Clinical Trials in Oncology | 2015-06-25 |
| Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer (NCT02646462) | Michael Bau Mortensen | 2015-06-01 |
| Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 (NCT02541370) | Chinese PLA General Hospital | 2015-06-01 |
| Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining (NCT02486497) | Seoul National University Hospital | 2015-06-01 |
| Resection of the Nerve Plexus on the Right Half of Celiac and SMA Associated With Extended Pancreatoduodenectomy in the Surgical Treatment for Adenocarcinoma of the Head of Pancreas (NCT02514928) | Fudan University | 2015-06-01 |
| Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk (NCT02478892) | Abramson Cancer Center at Penn Medicine | 2015-05-01 |
| Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction (NCT04420039) | Hospital Universitari de Bellvitge | 2015-05-01 |
| Pillars4Life Trial (NCT02465892) | Duke University | 2015-05-01 |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer (NCT02449967) | Fuda Cancer Hospital, Guangzhou | 2015-05-01 |
| Survivorship Promotion In Reducing IGF-1 Trial (NCT02431676) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-05-01 |
| A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer (NCT02399137) | Merrimack Pharmaceuticals | 2015-05-01 |
| Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer (NCT02465983) | University of Pennsylvania | 2015-05-01 |
| Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients (NCT02400398) | Andrew Hendifar, MD | 2015-04-27 |
| Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy (NCT02457156) | University of Liverpool | 2015-04-23 |
| Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma (NCT02289898) | OncoMed Pharmaceuticals, Inc. | 2015-04-20 |
| Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma (NCT02329717) | Phoenix Biotechnology, Inc | 2015-04-01 |
| A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours (NCT02423239) | e-Therapeutics PLC | 2015-04-01 |
| Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer (NCT02405585) | NewLink Genetics Corporation | 2015-04-01 |
| Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) (NCT02423954) | Western Regional Medical Center | 2015-04-01 |
| Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects (NCT02284139) | Dong-A University Hospital | 2015-04-01 |
| Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer (NCT02311361) | National Cancer Institute (NCI) | 2015-03-25 |
| Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy (NCT02238847) | Boston Scientific Corporation | 2015-03-24 |
| Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer (NCT02361320) | M.D. Anderson Cancer Center | 2015-03-09 |
| A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors (NCT02403271) | Pharmacyclics LLC. | 2015-03-01 |
| A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer (NCT02237157) | RenovoRx | 2015-03-01 |
| C-VISA BikDD: Liposome in Advanced Pancreatic Cancer (NCT00968604) | M.D. Anderson Cancer Center | 2015-03-01 |
| Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer (NCT02305186) | Craig L Slingluff, Jr | 2015-03-01 |
| Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer (NCT02393703) | Memorial Sloan Kettering Cancer Center | 2015-03-01 |
| Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer (NCT02295956) | M.D. Anderson Cancer Center | 2015-02-02 |
| Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma (NCT02345408) | Amgen | 2015-02-01 |
| Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer (NCT02283372) | Washington University School of Medicine | 2015-01-21 |
| Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue (NCT03140592) | Stony Brook University | 2015-01-14 |
| Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer (NCT02355119) | Azienda Ospedaliero, Universitaria Pisana | 2015-01-01 |
| Clinical Impact of EUS Elastography Mean Strain Histograms (SH) and Contrast Peak-enhancement in Focal Pancreatic Masses and Lymph Nodes (NCT02459041) | University of Medicine and Pharmacy Craiova | 2015-01-01 |
| Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS Study (NCT02756468) | University of Roma La Sapienza | 2015-01-01 |
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) (NCT02707328) | The Cooper Health System | 2015-01-01 |
| S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer (NCT02131493) | Zhejiang University | 2015-01-01 |
| Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer (NCT02343835) | Fuda Cancer Hospital, Guangzhou | 2015-01-01 |
| Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies (NCT02340728) | Memorial Sloan Kettering Cancer Center | 2015-01-01 |
| A Clinical Research of CAR T Cells Targeting CEA Positive Cancer (NCT02349724) | Southwest Hospital, China | 2014-12-01 |
| Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) (NCT02331251) | Western Regional Medical Center | 2014-12-01 |
| Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer (NCT02347618) | University of Rochester | 2014-12-01 |
| hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse (NCT02960594) | Inovio Pharmaceuticals | 2014-12-01 |
| Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer Surgery (NCT02260128) | Michael Bau Mortensen | 2014-11-01 |
| Early Palliative Care on Quality of Life of Advanced Cancer Patients (NCT02988635) | Azienda Ospedaliero-Universitaria di Parma | 2014-11-01 |
| BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer (NCT02155088) | H. Lee Moffitt Cancer Center and Research Institute | 2014-10-30 |
| Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer (NCT03077334) | Yonsei University | 2014-10-07 |
| Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer (NCT02278458) | Betta Pharmaceuticals Co., Ltd. | 2014-10-01 |
| Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection (NCT02241187) | Memorial Sloan Kettering Cancer Center | 2014-09-12 |
| Invasive Treatment of Pain Associated With Pancreatic Cancer on Different Levels of WHO Analgesic Ladder (NCT02424279) | Medical University of Gdansk | 2014-09-01 |
| Study of Gemcitabine and Abraxane for Pancreas Cancer (NCT02242409) | Georgetown University | 2014-09-01 |
| Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body (NCT02208024) | University of Cincinnati | 2014-08-27 |
| Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer (NCT01905150) | Bruckner Oncology | 2014-08-13 |
| (PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer (NCT02132403) | University of Illinois at Chicago | 2014-08-01 |
| Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice (NCT02277834) | University of Alabama at Birmingham | 2014-08-01 |
| Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer (NCT02550847) | National Taiwan University Hospital | 2014-08-01 |
| Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer (NCT01895790) | Johns Hopkins University | 2014-07-01 |
| Stereotactic Body Radiotherapy Dose Escalation in Pancreatic Cancer (NCT02454140) | University of California, San Diego | 2014-06-20 |
| Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer (NCT02191761) | Biosplice Therapeutics, Inc. | 2014-06-19 |
| A Study of Regorafenib in Advanced Pancreatic Cancer Patients (NCT02080260) | Wake Forest University Health Sciences | 2014-06-06 |
| Comparison Between Base and Cover Slide From Endoscopic Ultrasound Guided Fine Needle Aspiration for Pancreatic Cancer (NCT02190071) | Seoul National University Hospital | 2014-06-01 |
| A Study of Ruxolitinib in Pancreatic Cancer Patients (NCT02119663) | Incyte Corporation | 2014-06-01 |
| Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer (NCT02138383) | H. Lee Moffitt Cancer Center and Research Institute | 2014-05-22 |
| Longitudinal Pancreatic Cancer Study (NCT02250638) | Fujirebio Diagnostics, Inc. | 2014-05-01 |
| A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation (NCT02042378) | pharmaand GmbH | 2014-04-01 |
| Prospective Evaluation of Diagnostic Accuracy of Endoscopic Ultrasound-guided Fine Needle Aspiration and Biopsy (EUS-FNAB) in the Absence of Rapid Onsite Evaluation (NCT02079285) | Kangbuk Samsung Hospital | 2014-04-01 |
| Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer (NCT02106871) | The University of Texas Medical Branch, Galveston | 2014-04-01 |
| Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer (NCT02132325) | Mayo Clinic | 2014-04-01 |
| Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study (NCT02116322) | Johns Hopkins University | 2014-04-01 |
| Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer (NCT03469375) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2014-04-01 |
| Pancreatic Cancer Early Detection Program (NCT02206360) | White Plains Hospital | 2014-04-01 |
| Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel (NCT02106884) | Universitaire Ziekenhuizen KU Leuven | 2014-04-01 |
| Prospective Analysis of Robot-Assisted Surgery (NCT02292914) | Instituto do Cancer do Estado de São Paulo | 2014-03-10 |
| Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) (NCT02080650) | Duke University | 2014-03-01 |
| Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation (NCT02159248) | Orlando Health, Inc. | 2014-03-01 |
| Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1) (NCT02117479) | Incyte Corporation | 2014-03-01 |
| TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer (NCT03914950) | Medical University of Graz | 2014-02-07 |
| Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine (NCT01845337) | University of Edinburgh | 2014-02-05 |
| Neoadjuvant Treatment in Resectable Pancreatic Cancer (NCT01900327) | Universitätsklinikum Hamburg-Eppendorf | 2014-02-01 |
| BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial (NCT02022033) | Brown University | 2014-02-01 |
| Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine) (NCT01845805) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-01-10 |
| A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046. (NCT02021500) | Celgene | 2014-01-02 |
| Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer (NCT02416609) | Azienda Ospedaliero-Universitaria di Modena | 2014-01-01 |
| Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy (NCT02628860) | National Cancer Center, Korea | 2014-01-01 |
| GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients (NCT03869294) | Zhejiang University | 2014-01-01 |
| Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer (NCT02047500) | ImmunoGenesis | 2014-01-01 |
| Pancreatic Cancer Recurrence in the Netherlands (NCT04605237) | UMC Utrecht | 2014-01-01 |
| Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy (NCT01931449) | Southwest Hospital, China | 2014-01-01 |
| Improving Pancreatic Cancer Care by the Use of Computational Science and Technology (NCT06055010) | UMC Utrecht | 2014-01-01 |
| Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail (NCT02117895) | Fudan University | 2014-01-01 |
| Loop-tipped Guidewire in Selective Biliary Cannulation (NCT02028845) | Ajou University School of Medicine | 2014-01-01 |
| Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy (NCT01941342) | Southwest Hospital, China | 2014-01-01 |
| Pancreatic Resection, Malnutrition and Readmission (NCT01947166) | Duke University | 2013-12-01 |
| Investigator's Initiated Phase II Study for Pancreatic Cancer Patients (NCT01659502) | Tiltan Pharma Ltd. | 2013-12-01 |
| Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer (NCT02024633) | Betta Pharmaceuticals Co., Ltd. | 2013-12-01 |
| Efficacy and Safety of Endoscopic Ultrasound Guided Fine-needle Injection of Dendritic Cells Vaccination Into Unresectable Pancreatic Cancer (NCT01897636) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2013-12-01 |
| Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer (NCT01956812) | Gilead Sciences | 2013-12-01 |
| Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials (NCT02020252) | University of Chicago | 2013-11-26 |
| Electroporation (NanoKnife) as Treatment for Advanced Pancreatic Cancer (NCT02079623) | Aalborg University Hospital | 2013-11-01 |
| Diagnosis of Bile Duct Strictures (NCT02000999) | Washington University School of Medicine | 2013-11-01 |